Pharmacodynamic Comparison of Pitavastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease Treated With Dual Antiplatelet Therapy - The PORTO Trial

Trial Profile

Pharmacodynamic Comparison of Pitavastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease Treated With Dual Antiplatelet Therapy - The PORTO Trial

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Nov 2015

At a glance

  • Drugs Atorvastatin (Primary) ; Pitavastatin (Primary) ; Aspirin; Clopidogrel
  • Indications Coronary artery disease; Thrombosis
  • Focus Pharmacodynamics
  • Acronyms PORTO
  • Most Recent Events

    • 18 Nov 2015 Status changed from not yet recruiting to active, no longer recruiting as per results published in Circulation Journal
    • 06 Mar 2013 Planned end date changed from 1 Dec 2013 to 1 Dec 2017 as reported by ClinicalTrials.gov.
    • 06 Mar 2013 Planned initiation date changed from 1 Jul 2012 to 1 Jan 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top